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an immunohistochemical marker that determines the prognosis has not
been detected yet
Methods: 84 cases of clear cell renal cell carcinoma diagnosed between
2008-2015 in our institution were re-evaluated by two pathologists who
were blind to outcome. One representative block from of all tumours was
selected to perform Bcl2 immunhistochemistry. The immunoreactivity
was evaluated semi-quantitatively based on the percentage of positively
stained cells (proportion) and also staining intensity.
Results: Our follow-up range was 4-141 months. Statistical analysis re-
vealed that there was an inverse relationship between bcl 2 expression and
clinical course. The decreased levels of bcl2 were statistically related with
metastasis, shorter disease free survival and shorter overall survival on
both univariate and multivariate analysis (univariate analysis p=0.019,
p=0.05, p=0.009 respectively, multivariate analysis OR=2.136, 95%
CI=0.222–0.625, p= 0.012, HR=1.856, 95% CI=0.034–0.725, p=
0.018, OR=1.552, 95%CI=0.703–0.645, p= 0.06) Kaplan-Meier survival
curves revealed statistical significance (p< 0.05) between decreased ex-
pression levels and strong and moderate levels.
Conclusion: The role of apoptotic mechanisms in both programmed cell
death and tumour formation have not been fully elucidated. There may be
compensatory relations that we do not yet know among these complex
chain of events.
However, our study may constitute a base for further research in the field
of prognostic estimation, as bcl-2 expression is statistically significant
with metastasis, recurrence, and overall survival.
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Background & objectives: In 2019, new renal entities were described
that include an oncocytic tumour that is CD117 negative and diffusely
CK7 and e-cadherin positive, with specific morphologic features. Our
aim was to retrieve cases that could fit this new entity.
Methods:We analysed 47 resections and 8 needle core biopsies of renal
cell tumours from January/2018 to January/2020.We excluded 7 biopsies
and 45 resections based on the incompatible morphology or immunohis-
tochemistry required for this diagnosis. Immunohistochemical panel of
CK7, CD117 and e-cadherin was performed, when missing. Clinical
history and outcome was examined, when provided.
Results: In the last 2 years, in our institution, we found 3 oncocytic renal
cell tumours with inconclusive sub-classification that fit the description
for this new entity: Low-grade oncocytic tumour. The 3 selected cases
belonged to men between 69 and 72 years old, were unifocal with sizes
ranging from 15mm to 60mm, grossly well delimited, with yellow and
brown areas. All patients are currently alive and well, one still awaiting
surgery. All cases have round to oval nuclei, low Fuhrman grade (1-2),
solid/tubular growth pattern, diffuse positivity for CK7 and e-cadherin,
and were negative for CD117.
Conclusion: Renal cell oncocytic tumours sometimes show non-specific
morphology and immunophenotype leading to inconclusive sub-
classifications between multiple renal cell tumours with oncocytic change.
This optimization in classification can help reduce diagnostic observer var-
iability and discover potential therapeutic targets or outcome predictors.
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Background & objectives: Intraluminal inclusions (IIn) in prostate
cancer (PCa) causes the development of inflammation, tumour
progression and metastasis. However, their effect on apoptosis
remains unstudied.
Objective: To study the influence of intraluminal inclusions on apoptosis
of prostate cancer cells.
Methods: 60 PCa samples (group within 30 samples of PCa with IIn
(prostatic calculi and corpora amylacea) and group of 30 samples without
IIn) were used for study. All samples were examined by hematoxylin-eosin
staining and by immunohistochemistry (p53, Bax and Casp3). All data
were analysed by Shapiro-Wilk test, Mann-Whitney’s U-test and
Student’s t-test.
Results: We have indicated no significant difference in expression of p53
protein between groups. However, the localization of p53-positive cells was
associated with IIn. PCa with IIn had a significant higher expression of Bax
(p<0.001) and Casp3 (p<0.001). It may indicate a stimulation of apoptosis by
IIn. The intensity of immunostaining was also higher in PCa tissue with IIn.
Conclusion: IIn promote cell injury of PCa cells and modification of cell
live cycle. It results in higher level of apoptosis in tumour tissue. This may
indicate a adverse effect of IIn on the course and progression of PCa.
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Background & objectives: The authors’ aim is to assess the correlations
between themain tumour constitutive elements evaluated using the fractal
dimension (FD) and three main features of tumour cells in prostate ade-
nocarcinoma (PC).
Methods: 269 fields with different PC architectural patterns were select-
ed then classically and immunohistochemically stained.
Images were binarized. The FD (<1.5=“linear-like”-LLD and >1.5=“ar-
ea-like”-ALD distributions) was computed for each binary image.
Immunohistochemical stain intensities were assessed through a proprie-
tary computational algorithm.
Tumour cells architecture-GO, tumour stroma architecture-TC, vascular
network-VN, the capacity to degrade extracellular matrix-ECMD, inter-
cellular adhesion-ICA and aggressiveness degree-AgD were assessed.
Results:MMP9 intensity trend was smoothly descending as GO evolved
towards ALD and ascending as TC evolved towards ALD distribution.
PTEN intensity, instead smoothly increased as GO evolved towards ALD
and decreased as TC evolved towards ALD.
MMP2 intensity trend was descending as both GO and TC evolved to-
wards ALD.
E-CAD intensity trend was ascending as both GO and TC evolved to-
wards ALD.
MMP9 and E-CAD intensities had no correlation with VNwhileMMP2 and
PTEN had both a smoothly descending trend as VN evolved towards ALD.
Conclusion: Tumour cell behaviour (ECMD, ICA, AgD) is different
according to architectural distribution of tumour cells architecture, tu-
mour stroma architecture and vascular network, suggesting a dynamic
interrelation between the heterogeneous tumour cell population and tu-
mour microenvironment.
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